Skip to content
Screener

Reported November 5, 2025 · Before market open

EPS-$0.33Beat by $0.15
EPS estimate-$0.48

Next report

Dec 14, 2026 (in 3 months)
EPS estimate-$0.33

FAQ

When did Lexeo Therapeutics, Inc. report Q3 2025 earnings?
Lexeo Therapeutics, Inc. (LXEO) reported Q3 2025 earnings on November 5, 2025 before market open.
What were Lexeo Therapeutics, Inc.'s Q3 2025 revenue and EPS?
Lexeo Therapeutics, Inc. reported eps of $-0.33 for Q3 2025.
Did Lexeo Therapeutics, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.48 by $0.15.
How did Lexeo Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 62.9% from $-0.89.
Where can I find Lexeo Therapeutics, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-265755) and the 10-Q periodic report (0001193125-25-265757) directly on SEC EDGAR. The filing index links above go to sec.gov.